Iconography : Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis

[1]  J. Rode,et al.  Hyperoxaluria is related to whewellite and hypercalciuria to weddellite: What happens when crystalline conversion occurs? , 2016 .

[2]  A. Blanchard,et al.  Désordres de la magnésémie , 2015 .

[3]  M. Daudon,et al.  Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis. , 2015, The Journal of urology.

[4]  M. Daudon,et al.  Demographics and Characterization of 10,282 Randall Plaque-Related Kidney Stones , 2015, Medicine.

[5]  U. Maggiore,et al.  Recurrent 2,8‐Dihydroxyadenine Nephropathy: A Rare but Preventable Cause of Renal Allograft Failure , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  B. Canales,et al.  Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[7]  J. Lieske,et al.  Sustained Pyridoxine Response in Primary Hyperoxaluria Type 1 Recipients of Kidney Alone Transplant , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  M. Daudon,et al.  Therapy modifies cystine kidney stones at the macroscopic scale. Do such alterations exist at the mesoscopic and nanometre scale , 2014 .

[9]  M. Daudon.  Vitamine D, plaque de Randall et lithiase : existe-t-il un lien ? , 2013 .

[10]  F. Grases,et al.  Renal papillary calcification and the development of calcium oxalate monohydrate papillary renal calculi: a case series study , 2013, BMC Urology.

[11]  J. Groothoff,et al.  Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  E. Salido,et al.  Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  A. Alaya,et al.  Changes in Urinary Stone Composition in the Tunisian Population: A Retrospective Study of 1,301 Cases , 2012, Annals of laboratory medicine.

[14]  R. Wallace,et al.  Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. , 2011, The American journal of clinical nutrition.

[15]  M. Daudon,et al.  Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism? , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  M. Daudon,et al.  Composition and morphology of phosphate stones and their relation with etiology , 2010, Urological Research.

[17]  M. Daudon,et al.  Decreased kidney function and crystal deposition in the tubules after kidney transplant. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Seth K Bechis,et al.  Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. , 2010, The Journal of urology.

[19]  M. Daudon,et al.  Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. , 2010, Journal of the American Society of Nephrology : JASN.

[20]  L. Dimeglio,et al.  Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. , 2010, The Journal of clinical endocrinology and metabolism.

[21]  M. Econs,et al.  Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis. , 2009, The Journal of clinical endocrinology and metabolism.

[22]  Alain Mallet,et al.  Estimation of urinary stone composition by automated processing of CT images , 2009, Urological Research.

[23]  M. Stoller,et al.  Hyperoxaluria after modern bariatric surgery: case series and literature review , 2009, International Urology and Nephrology.

[24]  M. Daudon,et al.  Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. , 2009, Urology.

[25]  A. Evan,et al.  Clinical and laboratory characteristics of calcium stone‐formers with and without primary hyperparathyroidism , 2009, BJU international.

[26]  M. Daudon,et al.  Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques , 2009 .

[27]  M. Daudon,et al.  [Epidemiology of urolithiasis]. , 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[28]  M. Daudon,et al.  Peculiar morphology of stones in primary hyperoxaluria. , 2008, The New England journal of medicine.

[29]  J. Lingeman,et al.  Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. , 2008, Kidney international.

[30]  T. Strom,et al.  PHEX, FGF23, DMP1 and beyond , 2008, Current opinion in nephrology and hypertension.

[31]  N. Loh,et al.  Genetic causes of hypercalciuric nephrolithiasis , 2008, Pediatric Nephrology.

[32]  J. Lingeman,et al.  Renal histopathology of stone-forming patients with distal renal tubular acidosis. , 2007, Kidney international.

[33]  F. Coe,et al.  Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. , 2007, The Journal of urology.

[34]  M. Daudon,et al.  Type 2 diabetes increases the risk for uric acid stones. , 2006, Journal of the American Society of Nephrology : JASN.

[35]  M. Daudon,et al.  Drug-Induced Renal Calculi , 2006, Drugs.

[36]  A. Evan,et al.  Kidney stone disease. , 2005, The Journal of clinical investigation.

[37]  B. Hoppe,et al.  Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  M. Daudon,et al.  High prevalence of uric acid calculi in diabetic stone formers. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  J. Lingeman,et al.  Crystal-associated nephropathy in patients with brushite nephrolithiasis. , 2005, Kidney international.

[40]  M. Daudon,et al.  [Composition of renal stones currently observed in non-industrialized countries]. , 2004, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[41]  M. Stampfer,et al.  Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. , 2004, Journal of the American Society of Nephrology.

[42]  J. Lingeman,et al.  Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. , 2004, Kidney international.

[43]  H. Moutsopoulos,et al.  Clinical manifestations and early diagnosis of Sjögren syndrome. , 2004, Archives of internal medicine.

[44]  M. Fulop,et al.  Renal tubular acidosis, Sjögren syndrome, and bone disease. , 2004, Archives of internal medicine.

[45]  H. Simmonds,et al.  Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  C. Pak,et al.  Biochemical and physicochemical presentations of patients with brushite stones. , 2004, The Journal of urology.

[47]  N. Abate,et al.  The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. , 2004, Kidney international.

[48]  R. Paterson,et al.  Urine calcium and volume predict coverage of renal papilla by Randall's plaque. , 2003, Kidney international.

[49]  Beverley Adams-Huet,et al.  Predictive value of kidney stone composition in the detection of metabolic abnormalities. , 2003, The American journal of medicine.

[50]  R. Paterson,et al.  Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. , 2003, The Journal of clinical investigation.

[51]  M. Zafar,et al.  Management of pediatric urolithiasis in Pakistan: experience with 1,440 children. , 2003, The Journal of urology.

[52]  B. Gérard,et al.  Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. , 2002, The New England journal of medicine.

[53]  B. Adams-Huet,et al.  Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. , 2002, Kidney international.

[54]  V. Tasic,et al.  Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. , 2001, Journal of the American Society of Nephrology : JASN.

[55]  A. Sarkissian,et al.  Pediatric urolithiasis in Armenia: a study of 198 patients observed from 1991 to 1999 , 2001, Pediatric Nephrology.

[56]  W. Frawley,et al.  Biochemical profile of idiopathic uric acid nephrolithiasis. , 2001, Kidney international.

[57]  R. Manchanda,et al.  Nephrolithiasis on topiramate therapy. , 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[58]  M. Daudon,et al.  Crystalline phase differentiation in urinary calcium phosphate and magnesium phosphate calculi. , 1999, Scandinavian journal of urology and nephrology.

[59]  D. Leusmann,et al.  Potential contribution of optional urease-positive bacteria to idiopathic urinary calcium stone formation , 1996, Urological Research.

[60]  M. Daudon,et al.  Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  M. Daudon,et al.  2,8-dihydroxyadenine urolithiasis, an underdiagnosed disease , 1992, The Lancet.

[62]  M. Daudon,et al.  Urolithiasis in patients with end stage renal failure. , 1992, The Journal of urology.

[63]  M. H. Gault,et al.  Comparison of Patients with Idiopathic Calcium Phosphate and Calcium Oxalate Stones , 1991, Medicine.

[64]  J. Lingeman,et al.  The clinical implications of brushite calculi. , 1991, The Journal of urology.

[65]  J. Lingeman,et al.  Laxative abuse as a cause for ammonium urate renal calculi. , 1990, The Journal of urology.

[66]  S. Dretler,et al.  Cystine calculi--rough and smooth: a new clinical distinction. , 1989, The Journal of urology.

[67]  M. Daudon,et al.  Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis. , 1987, The Journal of urology.

[68]  G. Preminger,et al.  Nephrolithiasis from calcium supplementation. , 1987, The Journal of urology.

[69]  M. Daudon,et al.  PIRIDOXILATE-ASSOCIATED CALCIUM OXALATE URINARY CALCULI: A NEW METABOLIC DRUG-INDUCED NEPHROLITHIASIS , 1985, The Lancet.

[70]  U. Liberman,et al.  Hereditary hypophosphatemic rickets with hypercalciuria. , 1985, The New England journal of medicine.

[71]  F. Coe,et al.  Uric acid and calcium oxalate nephrolithiasis. , 1983, Kidney international.

[72]  B. Kogan,et al.  Renal calculi associated with incomplete distal renal tubular acidosis. , 1982, The Journal of urology.

[73]  D. Griffith,et al.  Infection-induced renal calculi. , 1982, Kidney international.

[74]  M. Kass,et al.  Acetazolamide and urolithiasis. , 1981, Ophthalmology.

[75]  T. A. Taylor,et al.  The endemic bladder stones of Indonesia---epidemiology and clinical features. , 1976, British journal of urology.

[76]  R. Chalmers,et al.  Metabolic investigations after xylitol infusion in human subjects. , 1976, The American journal of clinical nutrition.

[77]  G. L. Gardner.  Nucleation and crystal growth of calcium oxalate trihydrate , 1975 .

[78]  L. Persky,et al.  Calculus formation and ureteral colic following acetazolamide (diamox) therapy. , 1956, Journal of the American Medical Association.

[79]  H. Tiselius,et al.  Urolithiasis: Basic science and clinical practice , 2012 .

[80]  J. Lingeman,et al.  The role of Randall's plaques in the pathogenesis of calcium stones. , 2007, The Journal of urology.

[81]  H. Tiselius,et al.  Risk factors of calcium stone formation in patients with primary Sjögren's syndrome , 2004, Urological Research.

[82]  C. P. Davis,et al.  Intracellular crystal formation in bacteria from human urines: A contributing factor in urinary calculi , 2004, Urological Research.

[83]  N. Piaseu,et al.  Risk of Calcium Oxalate Nephrolithiasis after Calcium or Combined Calcium and Calcitriol Supplementation in Postmenopausal Women , 2000, Osteoporosis International.

[84]  S. Scheinman.  X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. , 1998, Kidney international.

[85]  M. Daudon,et al.  Contribution of Fourier transform infrared spectroscopy to the identification of urinary stones and kidney crystal deposits , 1997 .

[86]  E. W. Czerwinski,et al.  Calcium phosphate crystal formation in Escherichia coli from human urine: an in vitro study. , 1982, The Journal of urology.

[87]  B. Pinto,et al.  Isolation and characterization of uricine from uric acid stones. , 1976, Kidney international.